Article
Aicardi-Goutières syndrome type 6: report of ADAR variant and clinical outcome after ruxolitinib treatment in the neonatal period.
2024-01-24
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold> Aicardi-Goutières Syndrome is a monogenic type 1 interferonopathy with infantile onset, characterized by a variable degree of neurological damage. Approximately 7% of Aicardi-Goutières Syndrome cases are caused by pathogenic variants in the <italic>ADAR</italic> gene and are classified as Aicardi-Goutières Syndrome type 6. Here we present a new homozygous pathoge...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f444dff4-8b16-52a1-aa90-814bcd69d032
- DOI
- 10.21203/rs.3.rs-3854099/v1
